Top Abstracts: PE Thrombectomy, DVT Devices and Iliac Stents

FLASH Registry: Mechanical Thrombectomy for PE

Interim FLASH registry results in 230 patients found FlowTriever thrombectomy improved heart rate, pulmonary artery pressure, and cardiac index immediately post-procedure, with zero device related deaths, minimal ICU stay, and right ventricular recovery at 30 days in high and intermediate risk PE.

Tranexamic Acid for Postsclerotherapy Pigmentation

A systematic review found no direct studies of tranexamic acid for postsclerotherapy hyperpigmentation, but drew on melasma literature showing anti-angiogenic and anti-melanogenic effects, proposing it as a candidate treatment worth formal evaluation in vascular practice.

CLOUT Registry: Clearing Chronic DVT

CLOUT registry data in 64 chronic DVT patients found ClotTriever achieved a 90 percent median reduction in thrombus burden, with most patients moving to a better post-thrombotic syndrome category and improved pain and quality of life scores at 30 days.

VIVO Trial: Zilver Vena Stent for Iliofemoral Obstruction

Twelve month VIVO trial results in 243 patients found the Zilver Vena stent exceeded both safety and patency performance goals, with 90 percent patency and sustained improvement in venous clinical severity, disability, and quality of life scores through one year.